©The Author(s) 2025.
World J Gastrointest Surg. Oct 27, 2025; 17(10): 110801
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.110801
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.110801
Table 1 Characteristics of training and validation cohorts
| Clinicopathologic factors | Training set | P value | Validation set | P value | ||||||
| Score 0 | Score 1 | Score 2 | Statistic | Score 0 | Score 1 | Score 2 | Statistic | |||
| Sex | χ² = 6.85 | 0.033 | χ² = 5.66 | 0.059 | ||||||
| Male | 125 | 245 | 199 | 50 | 113 | 80 | ||||
| Female | 57 | 65 | 60 | 26 | 29 | 22 | ||||
| Age (years) | χ² = 1.46 | 0.481 | χ² = 3.80 | 0.15 | ||||||
| ≤ 65 | 112 | 190 | 147 | 51 | 76 | 58 | ||||
| > 65 | 70 | 120 | 112 | 25 | 66 | 44 | ||||
| Surgical approach | - | 0.176 | - | 0.03 | ||||||
| Open | 154 | 277 | 234 | 63 | 129 | 88 | ||||
| Laparoscopic | 27 | 32 | 22 | 8 | 11 | 14 | ||||
| Robotic | 1 | 3 | 1 | 5 | 2 | 0 | ||||
| Tumor location | χ² = 8.54 | 0.074 | χ² = 0.74 | 0.946 | ||||||
| Cardia and fundus of stomach | 98 | 160 | 123 | 36 | 67 | 48 | ||||
| Gastric body | 27 | 64 | 68 | 13 | 24 | 21 | ||||
| Pylorus | 57 | 86 | 68 | 27 | 51 | 33 | ||||
| Tumor site | χ² = 13.26 | 0.103 | - | 0.072 | ||||||
| Lesser curvature side | 148 | 246 | 193 | 67 | 114 | 77 | ||||
| Greater curvature side | 20 | 31 | 23 | 5 | 19 | 7 | ||||
| Anterior wall | 7 | 15 | 15 | 1 | 3 | 6 | ||||
| Posterior wall | 3 | 14 | 16 | 1 | 4 | 8 | ||||
| Total stomach | 4 | 4 | 12 | 2 | 2 | 4 | ||||
| Pathological type | χ² = 0.10 | 0.952 | χ² = 0.95 | 0.622 | ||||||
| Adenocarcinoma | 173 | 293 | 246 | 71 | 136 | 95 | ||||
| Others | 9 | 17 | 13 | 5 | 6 | 7 | ||||
| Differentiation degree | - | 0.1751 | - | 0.196 | ||||||
| Poorly differentiated | 130 | 235 | 177 | 60 | 92 | 68 | ||||
| Moderately differentiated | 50 | 72 | 81 | 16 | 48 | 33 | ||||
| Highly differentiated | 2 | 3 | 1 | 0 | 2 | 1 | ||||
| Tumor size | χ² = 68.59 | < 0.001 | χ² = 2.26 | 0.323 | ||||||
| ≤ 5 | 143 | 231 | 119 | 52 | 102 | 64 | ||||
| > 5 | 39 | 79 | 140 | 24 | 40 | 38 | ||||
| T stage | χ² = 28.96 | < 0.001 | χ² = 13.33 | 0.038 | ||||||
| T1 | 37 | 58 | 21 | 19 | 31 | 13 | ||||
| T2 | 22 | 31 | 15 | 14 | 19 | 8 | ||||
| T3 | 15 | 40 | 27 | 8 | 13 | 8 | ||||
| T4 | 108 | 181 | 196 | 35 | 79 | 73 | ||||
| N stage | χ² = 10.62 | 0.101 | χ² = 13.84 | 0.031 | ||||||
| N0 | 73 | 129 | 83 | 43 | 64 | 38 | ||||
| N1 | 32 | 51 | 42 | 7 | 33 | 17 | ||||
| N2 | 38 | 63 | 52 | 10 | 19 | 15 | ||||
| N3 | 39 | 67 | 82 | 16 | 26 | 32 | ||||
| Neutrophil-to-lymphocyte ratio | χ² = 183.54 | < 0.001 | χ² = 80.27 | < 0.001 | ||||||
| ≤ 2.98 | 181 | 276 | 132 | 76 | 126 | 51 | ||||
| > 2.98 | 1 | 34 | 127 | 0 | 16 | 51 | ||||
| Systemic immune-inflammation index | χ² = 344.47 | < 0.001 | χ² = 153.51 | < 0.001 | ||||||
| ≤ 560.54 | 182 | 267 | 68 | 76 | 125 | 26 | ||||
| > 560.54 | 0 | 43 | 191 | 0 | 17 | 76 | ||||
| Carcinoembryonic antigen | χ² = 2.39 | 0.303 | χ² = 2.06 | 0.358 | ||||||
| ≤ 4.02 | 130 | 211 | 167 | 52 | 106 | 68 | ||||
| > 4.02 | 52 | 99 | 92 | 24 | 36 | 34 | ||||
- Citation: Zhou EZ, Zhang LX, Han WX, Xu AM, Wei ZJ. Clinical significance of systemic inflammation response index and platelet–lymphocyte ratio in patients with stage I-III gastric cancer. World J Gastrointest Surg 2025; 17(10): 110801
- URL: https://www.wjgnet.com/1948-9366/full/v17/i10/110801.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i10.110801